高甘油三酯血症性胰腺炎诊疗进展

The progress in diagnosis and treatment of hypertriglyceridemic pancreatitis

急性胰腺炎(acute pancreatitis,AP)发病呈全球上升趋势。在美国,其发病率在过去十年增长了20%,每年大约有275000人因为急性胰腺炎住院治疗,并由此带来了约25亿美元的医疗支出。

Hypertriglyceridemia pancreatitis(HTGP)is a disease that seriously threatens human health and life.The primary cause is high triglycerides,and the factors that can be classified are primary and secondary.On the basis of hypertriglyceridemia,a variety of pathological mechanisms are involved in the pathogenesis of HTGP.In clinical diagnosis,there are various interference factors in blood lipid measurement,symptom analysis,and pancreatic enzyme measurement.HTGP treatment involves Intensive lipid-lowering treatment.